Attendees
Sponsors and
Exhibitors
Media
Contact us
Health tech Startups Pitching 2023
Giant Health's
"Healthcare Investment Show" – in partnership with Discovery Park
2024 10th December
Giant Health's Healthcare Investment Show is a must-attend for early-stage companies and investors. Hear from experts on the fundamentals, trends and challenges for life science and healthtech investment, as well as success stories from inspiring founders. This event also includes a range of innovative companies showcasing their business ideas - with one of the companies selected by the audience to win space at Discovery Park, with a wealth of business support. It's set to be an enlightening and informative day, where investors meet healthcare innovation at its finest!
This event has been specially curated with Discovery Park, one of the UK’s largest and leading science and technology parks, to provide valuable insights into the ever-evolving investment landscape. Not only will attendees hear first-hand from seasoned investors and pioneering founders on the challenges and opportunities inherent in securing investment, but they’ll also get the chance witness a number of exciting early-stage companies take to the stage to showcase their innovations to the audience.
This year’s showcase event is the culmination of Discovery Spark - an 8 week programme designed to arm early-stage science and tech businesses with the tools needed for future success, particularly in the art of honing their pitch. The winner of the programme will secure a generous prize valued at over £100,000, including £50,000 investment, a year of free lab space at Discovery Park, and comprehensive business support.
However, Giant Health’s Healthcare Investment event will see a selection of the remaining companies use their newfound skills to impress the audience with their innovative ideas. The audience will select a second ‘Wildcard’ winner to secure free lab or office space at Discovery Park for one year, along with a wealth of business support.
This event is tailor-made for entrepreneurs and founders working in biotech, medtech, digital health and healthtech seeking to navigate the complex word of investment. It’s also a chance for investors to meet with founders developing new opportunities in these cutting-edge sectors
About Discovery Park.
Discovery Park is a thriving life science community for visionary entrepreneurs and leaders and the ideal environment for businesses to start, scale and succeed. Its state-of-the-art facilities, including labs, offices, and manufacturing spaces, offer unrivaled flexibility, complemented by comprehensive support services to help businesses grow. Situated just over 1 hour from London, Discovery Park anchors Kent's burgeoning science and tech community, linked to the renowned Golden Triangle, which opens doors to abundant resources and opportunities. With over 160 companies and a dynamic tenant community ranging from startups to global giants like Pfizer, Discovery Park fosters innovation and collaboration across a diverse range of sectors and is home to Kent’s only Barclays Eagle Lab, providing impressive business support services.
Discovery Park is committed to nurturing the next generation of life science leaders and has its own investment fund, Discovery Park Ventures. The £3m fund invests in ambitious and exciting early-stage companies at start-up or to help leverage non-dilutive funding, backed by a vastly experienced and supportive team.
The Giant Health Healthcare Investment event is aimed at individuals with a specific interest in investing in, or securing investment in the life sciences industry. It is also open to healthcare professionals looking to understand investment opportunities in medical innovations, drug development and healthcare technologies.
- Biotech companies
- Medtech companies
- Healthtech companie
- Early-stage founders
- Entrepreneurs
- Investors
- Healthcare professionals
This showcase is set to bring together key players across the industry, including investors, scientists, founders and experts, offering a unique opportunity for both education and collaboration.
- Gain valuable insights from experts in the field
- Hear from businesses who have been in the same position and how they overcame any challenges for success
- Witness a number of inspiring companies showcase their innovations
- Network with potential collaborators and partners
Henry Whorwood - Head of Research & Consultancy at Beauhurst
Henry studied Classics at the University of Oxford before joining Beauhurst in 2014. He started and runs Beauhurst’s Research & Consultancy department which produces research on the UK’s startups and scaleups for organisations including the British Business Bank, Innovate UK and BEIS. Beauhurst provides research and insight to help professionals discover and track the UK’s high-growth companies. Beauhurst's data platform, available at beauhurst.com, provides data and alerts on the most ambitious businesses in Britain. It is used by leading organisations from across the world of finance, professional services, higher education and government to better understand the high-growth economy. Beauhurst regularly produce reports based on their data, examining a diverse range of topics from investment trends to mapping the UK’s scale-ups; from FinTech to BioTech.
Benjamin Storey - Head of Investor Connectivity, Platforms & Proposition, Barclays Bank UK
Benjamin is Head of Investor Connectivity, Platforms & Proposition covering Eagle Labs and the High Growth and Entrepreneurs team in Barclays Bank UK plc. A senior leader in the division, Benjamin has played important roles in the development of Eagle Labs growth journey. Benjamin is also the founder of the Barclays Demo Directory.
Max Herrmann, Managing Director Stifel
Max Herrmann joined Stifel in 2015. Based out of the London office, Max is an analyst in the Healthcare sector, covering Biotechnology and Pharmaceuticals.
Prior to joining Stifel, he was with Oriel Securities, Silence Therapeutics Plc (as CFO), Robert Fleming Securities, ING (as head of European Pharmaceutical and Biotechnology Research), Onyx Pharmaceuticals Inc. (as financial controller), and Arthur Andersen.
Max is a graduate of the University of Kent and holds a Chartered Accountant designation.
Jenny Tooth, Executive Chair UK Business Angels Association
Jenny Tooth OBE is Executive Chair of UK Business Angels Association UKBAA, the trade body for angel and early-stage investment in the UK that she established in 2012 where she was CEO until 2020. UKBAA supports and builds the angel and early-stage ecosystem across the UK with 96 angel groups, representing over 18,000 Angels, together with VC Funds, online platforms, accelerators and a range of wider organisations.
Jenny is an Angel investor herself and brings over 30 years’ experience of supporting businesses to access investment. Before setting up UKBAA, Jenny ran her own strategic innovation consultancy operating in London and Brussels and also co-founded Angel Capital Group, incorporating London Business Angels which was sold to Newable in 2017.
Jenny is passionate about increasing diversity in investment and currently leads the UK Women Angel UK Investment Task Force and is part of the Government’s Advisory Board for Female Entrepreneurship. She is a member of the Government’s Innovation Expert Group and sits on the London and MedCity Life Sciences Advisory Board and is a member of the Health Innovation Network Panel. On an international level, she sits on the Board for the UK-India Government Neev Impact Fund and is founding Board Director of Business Angels Europe.
Jenny has an MA in Economics from London School of Economics and Political Science and was also awarded an OBE in the Queen’s New Year Honours 2015 for her services to angel investment and small business.
Mayer Schreiber, CEO Discovery Park
As the CEO of Discovery Park, Mayer’s focus extends from nurturing start-ups to facilitating full-scale production, ensuring that Discovery Park is a globally recognised centre of excellence for science and innovation. Mayer's visionary leadership is driven by the goal of creating a vibrant and diverse ecosystem within the park, where our partner companies can thrive and access a multitude of resources seamlessly. His commitment to fostering such an environment underscores his belief that collaboration and synergy among the park's inhabitants are key drivers of innovation and progress.
Jane Kennedy, Chief Business Officer Discovery Park
Jane’s remit at Discovery Park is to drive strong business growth through the strategic development of the 220-acre science park; building an innovation hub, fostering a collaborative community on-site, and driving knowledge exchange. Jane is the former Senior Manager at Roslin BioCentre (known for the ground-breaking Dolly the Sheep research) and BioCity Scotland. She boasts a rich and extensive background in nurturing the expansion of Life Science Enterprises. She is a firm believer in fostering a collaborative ecosystem that nurtures the growth of life sciences and excels at building high-performing teams that attract ideal investment partners.
Renos Savva, Head of Innovation Discovery Park
Renos’s role at Discovery Park is to identify, support, and empower entrepreneurial scientists to thrive. He is a highly regarded Bio-business programme director and mentor leading him to develop the Discovery Spark self-audit programme. Renos excelled as an entrepreneur, co-founding Domainex, a company that received recognition from the Financial Times in 2018 as the 'fastest-growing drug discovery CRO in Europe’.
Joanna Gould, CEO VisusNano
Joanna obtained her PhD in developmental Neuroscience at the University of Southampton. After her MRes Joanna had a career change and went into corporate banking at Bank of America before deciding to come back to science. Joanna has also worked in research and development at an SME.
